ERCC2 and non-Hodgkin lymphoma: In the subgroup analysis according to the cancer site, a significant association with the ERCC2 Asp312Asn polymorphism was observed for bladder, esophageal, and gastric cancers; however, no significant association was observed for breast, head and neck, lung, prostate, and skin cancers, and non- Hodgkin lymphoma.